Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
Reiner Frey, Wolfgang Mück, Nina Kirschbaum, Jörn Krätzschmar, Gerrit Weimann, Georg WensingVolume:
9
Langue:
english
Pages:
1
DOI:
10.1186/1471-2210-9-s1-p15
Date:
August, 2009
Fichier:
PDF, 486 KB
english, 2009